No Data
No Data
Unicorn company "KK Group", which has applied for IPO in Hong Kong four times, had its prospectus invalidated again. The response is that this is a normal mechanism and the IPO is still advancing.
Unicorn company "KK Group", which has applied for IPO in Hong Kong four times, had its prospectus invalidated again. The response is that this is a normal mechanism and the IPO is still advancing.
KK Group submits a prospectus to be listed in Hong Kong for an IPO, exclusively sponsored by Morgan Stanley
On January 31, 2024, KK Group Company Holdings Limited (hereinafter referred to as “KK Group”), the actual holding company of Guangdong Express E-Commerce Co., Ltd. from Dongguan, Guangdong, submitted a prospectus on the Hong Kong Stock Exchange to be listed on the Hong Kong Main Board. This is another submission after three consecutive filing invalidations on November 4, 2021, January 20, 2023, and July 31, 2023.
Rekindle the money-making effect? Inventory and outlook of Hong Kong stock IPOs
Along with expectations of valuation restoration, market sentiment is expected to gradually pick up, and new share purchases may become popular again.
KK Group submits a prospectus for IPO listing in Hong Kong, co-endorsed by Morgan Stanley and Credit Suisse
On July 31, 2023, KK Group Company Holdings Limited (hereinafter referred to as “KK Group”), the substantive holding company of Guangdong Express E-Commerce Co., Ltd. from Dongguan, Guangdong, submitted a prospectus on the Hong Kong Stock Exchange to be IPO listed on the Hong Kong Main Board. This is another form submission after it failed two times on November 4, 2021 and January 20, 2023.
Is KK Group, whose performance is growing rapidly, “not profitable”? Let's take a look at the two core indicators
Will KK Group become “Aer Ophthalmology” in the retail sector?
In-vitro incubation, mergers and acquisitions are the style many physical enterprises choose when expanding rapidly. The most successful example is Ayr Ophthalmology. In the 10th year of the Lunar New Year, Aier Ophthalmology adopted in vitro incubation, mergers and acquisitions, and achieved rapid growth in the number of hospitals and revenue, making it a ten-fold market legend. KK Group, which is preparing to go public in Hong Kong recently, seems to have allowed the market to see the next “Aer Ophthalmology.” KK Group is an enterprise positioned as a trendy retailer. Although it is not the same track as Aer Ophthalmology, KK Group's strategic style of play is the same as Aer Ophthalmology. For example, Air Ophthalmology established private equity and
No Data
No Data